Incannex Healthcare Limited

IXHL42

Penny Stock

$1.87arrow_drop_down1.57%-$0.03

Penny Stock

IXHL42

$1.87

arrow_drop_down1.57%-$0.03

Penny Stock

Performance History

Key Stats
Open	$1.90
Prev. Close	$1.90
EPS	-1.27
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$32.63M
PE Ratio	-

	LOW	HIGH
Day Range	1.86	1.90
52 Week Range	0.80	12.68

Ratios







EPS	-1.27

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Incannex Healthcare Limited (IXHL)

Incannex Healthcare Limited (IXHL) is a healthcare company focused on developing and commercializing novel cannabinoid medicines for various medical conditions. The company is dedicated to improving the lives of patients through the safe and effective use of cannabis-based therapies. With a strong pipeline of product candidates and a commitment to clinical research, Incannex is positioned to be a leader in the emerging field of medicinal cannabis.

One of the key factors driving Incannex's growth potential is its diversified product portfolio. The company has multiple product candidates in various stages of development, targeting conditions such as obstructive sleep apnea, traumatic brain injury, and post-traumatic stress disorder. By addressing a range of medical conditions, Incannex aims to capture a significant share of the growing medicinal cannabis market.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Mr. Joel Bradley Latham
Headquarters: Melbourne
Employees: 0
Exchange: NASDAQ

add Incannex Healthcare Limited to watchlist

Keep an eye on Incannex Healthcare Limited

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the market capitalization of Incannex Healthcare Limited (IXHL)?

Incannex Healthcare Limited (IXHL) has a market capitalization of $32.64M. The average daily trading volume is 9.85K, indicating the stock's liquidity and investor engagement.

help

What is Incannex Healthcare Limited's (IXHL) price per share?

The current price per share for Incannex Healthcare Limited (IXHL) is $1.87. The stock has seen a price change of -$0.03 recently, indicating a -1.58% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Incannex Healthcare Limited (IXHL)?

For Incannex Healthcare Limited (IXHL), the 52-week high is $12.68, which is 578.07% from the current price. The 52-week low is $0.8, the current price is 133.75% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Incannex Healthcare Limited (IXHL) a growth stock?

Incannex Healthcare Limited (IXHL) has shown an average price growth of 0.41% over the past three years. It has received a score of 15 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Incannex Healthcare Limited as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Incannex Healthcare Limited (IXHL) stock price performance year to date (YTD)?

As of the latest data, Incannex Healthcare Limited (IXHL) has a year-to-date price change of -57.5%. Over the past month, the stock has experienced a price change of 11.98%. Over the last three months, the change has been -46.11%. Over the past six months, the figure is -28.08%.

help

Is Incannex Healthcare Limited (IXHL) a profitable company?

Incannex Healthcare Limited (IXHL) has a net income of -$13.23M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -2.16K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.01M, with a revenue growth rate of 29.59%, providing insight into the company's sales performance and growth. The gross profit is $1.01M. Operating income is noted at -$17.71M. Furthermore, the EBITDA is -$14.21M.